AA
AlphaCentric Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-151,000
| Closed | -$2.22M | – | 230 |
|
|
2023
Q4 | $2.22M | Buy |
151,000
+5,500
| +4% | +$81K | 1.49% | 19 |
|
|
2023
Q3 | $2.66M | Buy |
145,500
+37,500
| +35% | +$687K | 1.51% | 16 |
|
|
2023
Q2 | $2.33M | Buy |
108,000
+100,500
| +1,340% | +$2.17M | 1.29% | 16 |
|
|
2023
Q1 | $220K | Buy |
+7,500
| New | +$220K | 0.15% | 142 |
|